Using non-invasive imaging to identify high-risk chronic kidney disease patients
Non-Invasive Imaging Biomarkers to Identify a High-Risk Chronic Kidney Disease Phenotype
This study is looking at a new, gentle way to use ultrasound to help find out which people with chronic kidney disease are at greater risk for serious problems like heart issues or kidney failure, so they can get the right care sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11030505 on NIH RePORTER |
What this research studies
This research investigates a new non-invasive imaging technique to identify patients with chronic kidney disease (CKD) who are at high risk for serious complications, such as cardiovascular disease and kidney failure. The approach involves using contrast-enhanced ultrasound to assess renal microvascular perfusion, which can provide insights into kidney health without the need for invasive biopsies. By analyzing how microbubble contrast agents move in the kidneys, researchers aim to better understand the progression of CKD and identify patients who may benefit from targeted interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney disease, particularly those showing signs of advanced disease or severe kidney damage.
Not a fit: Patients with acute kidney injury or those without chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and better management of high-risk CKD patients, potentially improving their health outcomes.
How similar studies have performed: Previous studies have shown promise in using imaging techniques to assess kidney health, suggesting that this approach may yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Srivastava, Anand — University of Illinois at Chicago
- Study coordinator: Srivastava, Anand
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.